Prajakta Tambe

Prajakta Tambe

Ph.D Biotechnology

Biotechnology

Prajakta Tambe, Ph.D. worked at Queen’s University Belfast on a project that focused on studying ‘Role of Tregs in Acute Respiratory Distress Syndrome'. Prajakta completed a Ph.D. in August 2020 at Agharkar Research Institute, University of Pune, India. Her work aimed to develop dendrimer-based nanoparticles for the targeted delivery of MCL-1 gene-specific siRNA to bring about apoptosis in breast and prostate cancer cells and in vivo breast cancer xenograft models.

Prajakta has hands-on-experience in molecular cloning/transformation, ELISA, Tregs isolation, flow cytometry, microbiology. Her Ph.D. work involved techniques like plasmid isolation, cloning, transfections, cell culture, SDS-western blotting/real-time PCR, animal handling, in vivo cancer model development. During her Ph.D., she had a chance to publish several research articles and reviews. This provided a plethora of knowledge on writing, writing styles, reference management software, editing to very minute details, and preparing scientific illustrations.

Articles from Prajakta

COVID-19 mRNA vaccine protects against ICU admission for 1 year

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Study finds dexamethasone and remdesivir treatment in hospitalized COVID-19 patients is associated with reduced neurological complications

Study finds dexamethasone and remdesivir treatment in hospitalized COVID-19 patients is associated with reduced neurological complications

The molecular context and substrate profiles of human cell surface receptor tyrosine kinases

The molecular context and substrate profiles of human cell surface receptor tyrosine kinases

Efficacy of miniaturized electrostatic precipitator respirators in removal of SARS-CoV-2 bioaerosols compared to N95 masks

Efficacy of miniaturized electrostatic precipitator respirators in removal of SARS-CoV-2 bioaerosols compared to N95 masks

Study suggests blunted serological responses not responsible for COVID-19 mortality

Study suggests blunted serological responses not responsible for COVID-19 mortality

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Study shows circular RNA vaccine provides robust protection against SARS-CoV-2 in mice and rhesus macaques

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

The evolution of the SARS-CoV-2 spike protein

The evolution of the SARS-CoV-2 spike protein

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.